中国经济网北京8月3日讯深圳证券交易所网站8月1日发布公告称，深圳证券交易所上市审核委员会2025 年第13次审议会议于2025年8月1日召开，审议结果显示，锦浪科技（300763）股份有限公司(以下简 称"锦浪科技"，300763.SZ)(向不特定对象发行可转债)符合发行条件、上市条件和信息披露要求。 上市委会议现场问询的主要问题： 无。 需进一步落实事项： 本次发行可转换公司债券每张面值为100元，按面值发行。 无。 根据锦浪科技于2025年7月21日披露的2025年度向不特定对象发行可转换公司债券募集说明书(修订 稿)，本次向不特定对象发行可转债募集资金总额不超过人民币167,658.38万元(含本数)，扣除发行费用 后募集资金净额将投资于分布式光伏电站项目、高电压大功率并网逆变器新建项目、中大功率混合式储 能逆变器新建项目、上海研发中心建设项目、数智化提升项目和补充流动资金项目。 锦浪科技本本次可转债的发行对象为持有中国证券登记结算有限责任公司深圳分公司证券账户的自然 人、法人、证券投资基金、符合法律规定的其他投资者等(国家法律、法规禁止者除外)。 锦浪科技本本次向不特定对象发行可转换公司债券的保荐机 ...

Group 1: Market Overview - Recent financial reports from international beauty leaders like L'Oréal and Procter & Gamble indicate a sequential improvement in growth rates for overseas brands in the Chinese market, particularly in functional skincare and medical aesthetics [1] - The beauty sector is experiencing significant changes, with a notable rise in domestic brands, highlighting a clear growth trend and increasing brand differentiation [1] Group 2: L'Oréal Performance - L'Oréal reported a sales figure of €22.47 billion for 1H25, reflecting a year-on-year growth of 3.0%, with Q1 and Q2 growth rates of 2.6% and 3.7% respectively [2] - The net profit for L'Oréal reached €3.783 billion, showing a 1.0% year-on-year increase [2] - The professional hair division led growth with a 6.5% increase, while mass skincare, premium cosmetics, and skin science segments grew by 2.8%, 2.0%, and 3.1% respectively [2] - The Chinese market showed a 3% year-on-year growth in Q2, with skin science and professional hair products performing particularly well [2] Group 3: Procter & Gamble Performance - Procter & Gamble's Q2 sales amounted to $20.889 billion, a 2% year-on-year increase, with net profit rising by 15% to $3.626 billion [3] - The beauty segment saw a slight increase of 0.2% year-on-year, while net profit in this division grew by 4% [3] - The skincare business in China continued to grow, although this was offset by a decline in North America, resulting in flat overall sales for the skincare segment [3] Group 4: Galderma Performance - Galderma reported a net sales figure of $2.448 billion for 1H25, marking a 12.2% year-on-year increase, with Q2 growth at 15.8% [4] - The company raised its full-year sales guidance to 12-14%, up from the previous 10-12% [4] - The injection aesthetics, daily skincare, and skin treatment segments grew by 9.8%, 7.7%, and 26.9% respectively, with botulinum toxin sales increasing by 14.7% [4] - Strong performance was noted in key markets such as Brazil, Canada, and mainland China, particularly in the injection aesthetics business [4]

V. 確認 不適用 FF301 呈交者： 聶小剛 職銜： 董事及聯席公司秘書 (董事、秘書或其他獲正式授權的人員) 第 10 頁 共 11 頁 v 1.1.1 FF301 在購回股份（股份被持作庫存股份）的情況下，「事件發生日期」應理解爲「發行人購回並以庫存方式持有股份的日期」。 份數目。 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 國泰海通證券股份有限公司(「本公司」) 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 證券代號 (如上市) 02611 說明 法定/註冊股份數目 面值 法定/註冊股本 上月底結存 3,505,759,848 RMB 1 RMB 3,505,759,848 增加 / 減少 (-) 0 RMB 0 本月底結存 3,505,759,848 RMB 1 RMB 3,505,759,848 證券代號 (如上市) 601211 說明 法定/註冊股份數目 面值 法定/註冊股本 上月底結存 14,123,948,848 RMB 1 RMB 14,123,94 ...

Group 1 - The core viewpoint of the article indicates that the zinc futures market is experiencing a net short position among the top 20 positions, with a difference of 4,971 contracts as of August 1 [1] - The main contract for zinc (沪锌2509) closed with a slight decrease of 0.53%, and the total trading volume for all contracts was 165,000 contracts, which is a decrease of 11,770 contracts from the previous day [1] - The top 20 positions show an increase in long positions by 1,796 contracts and an increase in short positions by 2,408 contracts compared to the previous day [1] Group 2 - The top three long positions are held by 中信期货 (CITIC Futures) with a total holding of 31,274 contracts, 东证期货 (Dongzheng Futures) with 13,079 contracts, and 国泰君安 (Guotai Junan) with 12,352 contracts [1] - The top three short positions are also led by 中信期货 (CITIC Futures) with 24,139 contracts, followed by 国泰君安 (Guotai Junan) with 10,508 contracts, and 永安期货 (Yongan Futures) with 8,447 contracts [1] - The top three firms increasing their long positions are 建信期货 (Jianxin Futures) with an increase of 639 contracts, 华泰期货 (Huatai Futures) with an increase of 407 contracts, and 国投期货 (Guotou Futures) with an increase of 315 contracts [1]

Core Viewpoint - The company is actively pursuing international expansion through localized operations and a general contracting model, with significant progress in Southeast Asia, the Middle East, and the Americas [2][3]. Group 1: International Expansion Strategy - The company aims to enter developed markets from 2025 to 2030 through "going out, localization, and general contracting" strategies, with orderly progress reported [2]. - A local factory in Indonesia has officially opened, with plans to gradually undertake product deliveries in Indonesia and surrounding countries by 2025 [2]. - In the Middle East, a factory in Saudi Arabia is under construction, expected to be operational in the second half of the year, alongside local partner operations [2]. - In the Americas, land and factory procurement in Mexico has been completed, with production plans in progress [2]. - The company is focusing on regional hubs for localized operations, with potential expansion into Africa and Europe [2]. Group 2: Product Development and Market Trends - The new generation of integrated terminal standards has been launched, with expectations for significant procurement in the second half of 2025, driven by a projected 800 billion yuan investment in the power grid [3]. - The company anticipates participating in multiple tenders for upgraded integrated terminals and dual-mode standard collection chips, which are expected to contribute significantly to revenue growth [3]. - The company is leveraging AI and digital energy solutions, focusing on core technology development in areas such as energy prediction and intelligent monitoring [3][4][5][6][7]. Group 3: Collaboration and Risk Management - The company is deepening collaboration with Huawei's digital power division to provide solutions for global green power and grid stability [8]. - A strong matrix structure is in place for international operations, with local project managers and industry experts to ensure effective market adaptation [9]. - The company is prioritizing projects with financial backing and government support to mitigate risks associated with political changes in emerging markets [9]. Group 4: Financial Performance - For the first half of 2025, the company reported a main revenue of 1.368 billion yuan, an increase of 11.88% year-on-year, and a net profit of 305 million yuan, up 12.24% [11]. - The second quarter of 2025 saw a main revenue of 813 million yuan, reflecting a year-on-year increase of 4.9% [11]. - The company's debt ratio stands at 34.83%, with a gross profit margin of 39.02% [11].

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 本月底法定/註冊股本總額： RMB 17,629,708,696 第 1 頁 共 11 頁 v 1.1.1 公司名稱: 國泰海通證券股份有限公司(「本公司」) 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02611 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,505,759,848 | RMB | | 1 RMB | | 3,505,759,848 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 3,505,7 ...

Core Insights - The潮玩谷子 (trendy toys) sector is still rapidly developing, with a relatively stable number of investment projects in the primary market despite a decline from peak levels. The secondary market is seeing increased activity from players, including stationery and cultural enterprises, as well as IP holders [1][2]. Investment Trends - Investment in the潮玩谷子 sector peaked in the mid-2010s, with over 40 investment events annually from 2015 to 2018. However, the number of events has decreased since 2022, stabilizing at 19 in 2022, 9 in 2023, and 11 in 2024, with 11 recorded by July 10, 2025 [2]. - The investment landscape is divided into three core directions: IP content, derivative products, and platform-type enterprises. The derivative products segment is the most favored, with projected investment proportions of 60% for derivative products, 40% for IP content, and 0% for platform-type projects in 2024 [3]. Valuation Changes - Hitcard's valuation fluctuated, starting at 30 million yuan in 2021 and peaking at 500 million yuan in 2022, before dropping to 150 million yuan in 2024 [4]. - Yiqi Culture's valuation grew rapidly from 100 million yuan in 2022 to 500 million yuan by February 2025 [4]. - 52TOYS maintained a leading valuation in the sector, increasing from 75 million yuan in 2015 to 4.273 billion yuan by May 2025, with plans to enter the secondary market [4]. - KAYOU's valuation reached 900 million USD in 2021, with plans to enter the secondary market as well [4]. - Xingyue Holdings maintained a valuation of 1.5 billion yuan since 2021 and is preparing to enter the secondary market [5].

致：香港交易及結算所有限公司 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 公司名稱: 國泰海通證券股份有限公司(「本公司」) 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02611 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,505,759,848 | RMB | | 1 RMB | | 3,505,759,848 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 3,505,759,848 | RMB | | 1 RMB | | 3,505,759,848 | | 2. 股份分類 | ...

30年期国债期货期货全合约总计成交14.07万手，比上一日减少1.22万手。全合约前20席位多头持仓13.17万手，比上一日增加4335 手。全合约前20席位空头持仓13.37万手，比上一日增加3265手。 根据合并数据显示，多头前三席位为中信期货，总持仓29010、国泰君安，总持仓19587、东证期货，总持仓9982；空头前三席位 为国泰君安，总持仓18016、中信期货，总持仓15922、东证期货，总持仓13626； 主力合约前20席位中，多头增仓前三名分别是：国泰君安、持仓14023、增仓744，东证期货、持仓8408、增仓691，中泰期货、持 仓1631、增仓454；多头减仓前三名分别是：国金期货、持仓2754、减仓-521，中信期货、持仓18387、减仓-326，格林大华、持 仓892、减仓-161； 主力合约前20席位中，空头增仓前三名分别是：国泰君安、持仓15924、增仓1582，一德期货、持仓2270、增仓768，银河期货、 持仓6902、增仓533；空头减仓前三名分别是：宏源期货、持仓3997、减仓-745，国金期货、持仓3569、减仓-485，国投期货、持 仓3608、减仓-428。 文章来 ...

Core Insights - The main contract for paraxylene (PX) 2509 experienced a decline of 2.41% as of August 1, with a trading volume of 141,700 contracts and a net short position among the top 20 positions of 1,951 contracts [1] - Total trading volume for all paraxylene contracts reached 274,900 contracts, an increase of 18,000 contracts from the previous day [1] - The top 20 positions showed a long position of 217,100 contracts, up by 32,600 contracts, while the short position was 227,900 contracts, an increase of 29,700 contracts [1] Long and Short Positions - The top three long positions were held by Guotai Junan with a total holding of 27,812 contracts, CITIC Futures with 19,052 contracts, and Dongzheng Futures with 16,082 contracts [1] - The top three short positions were also led by Guotai Junan with 51,604 contracts, followed by Dongzheng Futures with 18,360 contracts and CITIC Futures with 18,163 contracts [1] - Among the top 20 positions, the largest increase in long positions was seen in Galaxy Futures with an increase of 2,118 contracts, while the largest decrease was in Dongzheng Futures with a reduction of 2,464 contracts [1] Trading Activity - The trading activity for the main contract showed a significant increase in both long and short positions, indicating a shift in market sentiment [1][4] - The overall trading volume for all contracts indicates a robust market activity, with a total of 438,425 contracts traded across all positions [4] - The data reflects a competitive landscape among futures firms, with notable changes in both long and short positions across various members [4]